IFNA2 and systemic lupus erythematosus: Both Simoa plasma IFN-α2 and IFN-I score distinguished IFN-I–related disease from HDs (Fig 2, A and B), in agreement with previous findings comparing the interferon signature (NanoString) and IFN-α2 quantification (Simoa) in a large cohort of adult SLE patients.32